English

MIRATI THERAPEUTICS, INC.

EDGAR

MRTX Quarterly report (10-Q) · filed 2023-11-06

52 filing records in this dataset, filed from 2013-08-13 to 2023-11-06. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

16.4 million USD

2023 Q3 · USD

Exact inputs and evidence

Revenue: 16400000 USD Source

Operating margin

-1,049.11%

2023 Q3 · %

Exact inputs and evidence

Operating Income: -172054000 USD Source
Revenue: 16400000 USD Source

Operating cash flow

-144 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -465295000 USD Source
Operating Cash Flow: -321582000 USD Source

Free cash flow

-144 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -465295000 USD Source
Operating Cash Flow: -321582000 USD Source
Capital Expenditure: 1027000 USD Source
Capital Expenditure: 991000 USD Source

Cash and cash equivalents: 259 million USD 2023-09-30 Source
Exact value

258718000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 70.1 million shares 2023-09-30 Source
Exact value

70111309 shares

Reported share-count change

21.79% · 12.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

57568769 shares · 2022-09-30· Source
70111309 shares · 2023-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

38.2 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Revenue: 12436000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 11502000 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 7167000 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 13690000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 16400000 USD · 2023-07-01 – 2023-09-30 Source

Net income

-726 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Net income: -740867000 USD · 2022-01-01 – 2022-12-31 Source
Net income: -538392000 USD · 2022-01-01 – 2022-09-30 Source
Net income: -184586000 USD · 2023-01-01 – 2023-03-31 Source
Net income: -176913000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -161904000 USD · 2023-07-01 – 2023-09-30 Source

Operating cash flow

-594 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Operating cash flow: -570570000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -441770000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -190182000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -321582000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -190182000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -465295000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -321582000 USD · 2023-01-01 – 2023-06-30 Source

Capital expenditure

1.84 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Capital expenditure: 4851000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 4041000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 269000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 991000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 269000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 1027000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 991000 USD · 2023-01-01 – 2023-06-30 Source

Free cash flow

-596 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Operating cash flow: -570570000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -441770000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -190182000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -321582000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -190182000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -465295000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -321582000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 4851000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 4041000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 269000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 991000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 269000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 1027000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 991000 USD · 2023-01-01 – 2023-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-11-06.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2022-12-31
Operating income: 11 of 11 periods available· newest 2022-12-31
Net income: 11 of 11 periods available· newest 2022-12-31
Operating cash flow: 11 of 11 periods available· newest 2022-12-31
Capital expenditure: 11 of 11 periods available· newest 2022-12-31
Total assets: 7 of 11 periods available· newest 2022-12-31
Total liabilities: 7 of 11 periods available· newest 2022-12-31
Current assets: 7 of 11 periods available· newest 2022-12-31
Current liabilities: 7 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2022-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-82.7%

Prior period

USD 72.09 million

2021-01-01 – 2021-12-31
Current period

USD 12.44 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

12436000 − 72092000 = -59656000 USD

72092000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
12436000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MIRATI THERAPEUTICS, INC. · 2022-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Year-over-year change in Revenue: -59656000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 12436000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#882793 Filing: 000162828023005576 Input fundies:Revenue: 72092000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#883846 Filing: 000162828023005576
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 159.08 million

Prior period

−USD 581.78 million

2021-01-01 – 2021-12-31
Current period

−USD 740.87 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-740867000 − -581784000 = -159083000 USD

-581784000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-740867000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MIRATI THERAPEUTICS, INC. · 2022-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Year-over-year change in Net income: -159083000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -740867000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1076808 Filing: 000162828023005576 Input fundies:NetIncome: -581784000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1077984 Filing: 000162828023005576
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 181.77 million

Prior period

−USD 388.8 million

2021-01-01 – 2021-12-31
Current period

−USD 570.57 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-570570000 − -388800000 = -181770000 USD

-388800000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-570570000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MIRATI THERAPEUTICS, INC. · 2022-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Year-over-year change in Operating cash flow: -181770000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -570570000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1126991 Filing: 000162828023005576 Input fundies:OperatingCashFlow: -388800000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1128048 Filing: 000162828023005576
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-50.5%

Prior period

USD 9.8 million

2021-01-01 – 2021-12-31
Current period

USD 4.85 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

4851000 − 9795000 = -4944000 USD

9795000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
4851000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MIRATI THERAPEUTICS, INC. · 2022-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Year-over-year change in Capital expenditure: -4944000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4851000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1137857 Filing: 000162828023005576 Input fundies:CapitalExpenditure: 9795000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1138845 Filing: 000162828023005576
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 12.44 million 100% of revenue
Operating costs Derived USD 772.03 million 6,208% of revenue
Operating income −USD 759.59 million −6,108% of revenue
Tax, interest and other Derived −USD 18.72 million −151% of revenue
Net income −USD 740.87 million −5,957% of revenue

Cash

Operating cash flow −USD 570.57 million −4,588% of revenue
Capital expenditure USD 4.85 million 39% of revenue
Free cash flow Derived −USD 575.42 million −4,627% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Operating loss: operating costs were 894% of revenue.
2019 Operating loss: operating costs were 6,760% of revenue.
2020 Operating loss: operating costs were 2,857% of revenue.
2021 Operating loss: operating costs were 895% of revenue.
2022 Operating loss: operating costs were 6,208% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	0	83779000 Derived	-83779000	-661000 Derived	-83118000	-68213000 Derived	Source 2016-01-01 – 2016-12-31: 0 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -83779000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -83118000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -68017000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 196000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	0	71535000 Derived	-71535000	-1105000 Derived	-70430000	-64787000 Derived	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -71535000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -70430000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -64706000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 81000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	12926000	115553000 Derived	-102627000	-4209000 Derived	-98418000	-70218000 Derived	Source 2018-01-01 – 2018-12-31: 12926000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -102627000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -98418000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -70096000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 122000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	3335000	225439000 Derived	-222104000	-8848000 Derived	-213256000	-149278000 Derived	Source 2019-01-01 – 2019-12-31: 3335000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -222104000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -213256000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -147726000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1552000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	13398000	382761000 Derived	-369363000	-11426000 Derived	-357937000	-275898000 Derived	Source 2020-01-01 – 2020-12-31: 13398000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -369363000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -357937000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -271531000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 4367000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	72092000	645273000 Derived	-573181000	8603000 Derived	-581784000	-398595000 Derived	Source 2021-01-01 – 2021-12-31: 72092000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -573181000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -581784000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -388800000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 9795000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	12436000	772025000 Derived	-759589000	-18722000 Derived	-740867000	-575421000 Derived	Source 2022-01-01 – 2022-12-31: 12436000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -759589000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -740867000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -570570000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 4851000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 12.4M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	0	Revenue: 0 Open source
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	12926000	Revenue: 12926000 Open source
20192019-12-31	Revenue	3335000	Revenue: 3335000 Open source
20202020-12-31	Revenue	13398000	Revenue: 13398000 Open source
20212021-12-31	Revenue	72092000	Revenue: 72092000 Open source
20222022-12-31	Revenue	12436000	Revenue: 12436000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-82.7% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 12926000 Open source Revenue: 0 Open source
20192019-12-31	Year over year	-74.2%	Revenue: 3335000 Open source Revenue: 12926000 Open source
20202020-12-31	Year over year	301.7%	Revenue: 13398000 Open source Revenue: 3335000 Open source
20212021-12-31	Year over year	438.1%	Revenue: 72092000 Open source Revenue: 13398000 Open source
20222022-12-31	Year over year	-82.7%	Revenue: 12436000 Open source Revenue: 72092000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -6,108% 2022

Net margin -5,957.4% 2022

Free cash flow margin -4,627.1% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	Not reported	Operating Income: -83779000 Open source Revenue: 0 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -71535000 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	-794%	Operating Income: -102627000 Open source Revenue: 12926000 Open source
20192019-12-31	Operating margin	-6,659.8%	Operating Income: -222104000 Open source Revenue: 3335000 Open source
20202020-12-31	Operating margin	-2,756.9%	Operating Income: -369363000 Open source Revenue: 13398000 Open source
20212021-12-31	Operating margin	-795.1%	Operating Income: -573181000 Open source Revenue: 72092000 Open source
20222022-12-31	Operating margin	-6,108%	Operating Income: -759589000 Open source Revenue: 12436000 Open source
20162016-12-31	Net margin	Not reported	Net Income: -83118000 Open source Revenue: 0 Open source
20172017-12-31	Net margin	Not reported	Net Income: -70430000 Open source Revenue: 0 Open source
20182018-12-31	Net margin	-761.4%	Net Income: -98418000 Open source Revenue: 12926000 Open source
20192019-12-31	Net margin	-6,394.5%	Net Income: -213256000 Open source Revenue: 3335000 Open source
20202020-12-31	Net margin	-2,671.6%	Net Income: -357937000 Open source Revenue: 13398000 Open source
20212021-12-31	Net margin	-807%	Net Income: -581784000 Open source Revenue: 72092000 Open source
20222022-12-31	Net margin	-5,957.4%	Net Income: -740867000 Open source Revenue: 12436000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -68017000 Open source Capital Expenditure: 196000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -64706000 Open source Capital Expenditure: 81000 Open source
20182018-12-31	Free cash flow margin	-543.2%	Revenue: 12926000 Open source Operating Cash Flow: -70096000 Open source Capital Expenditure: 122000 Open source
20192019-12-31	Free cash flow margin	-4,476.1%	Revenue: 3335000 Open source Operating Cash Flow: -147726000 Open source Capital Expenditure: 1552000 Open source
20202020-12-31	Free cash flow margin	-2,059.2%	Revenue: 13398000 Open source Operating Cash Flow: -271531000 Open source Capital Expenditure: 4367000 Open source
20212021-12-31	Free cash flow margin	-552.9%	Revenue: 72092000 Open source Operating Cash Flow: -388800000 Open source Capital Expenditure: 9795000 Open source
20222022-12-31	Free cash flow margin	-4,627.1%	Revenue: 12436000 Open source Operating Cash Flow: -570570000 Open source Capital Expenditure: 4851000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -570.6M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-68017000	Operating Cash Flow: -68017000 Open source
20172017-12-31	Operating cash flow	-64706000	Operating Cash Flow: -64706000 Open source
20182018-12-31	Operating cash flow	-70096000	Operating Cash Flow: -70096000 Open source
20192019-12-31	Operating cash flow	-147726000	Operating Cash Flow: -147726000 Open source
20202020-12-31	Operating cash flow	-271531000	Operating Cash Flow: -271531000 Open source
20212021-12-31	Operating cash flow	-388800000	Operating Cash Flow: -388800000 Open source
20222022-12-31	Operating cash flow	-570570000	Operating Cash Flow: -570570000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -575.4M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-68213000	Operating Cash Flow: -68017000 Open source Capital Expenditure: 196000 Open source
20172017-12-31	Free cash flow	-64787000	Operating Cash Flow: -64706000 Open source Capital Expenditure: 81000 Open source
20182018-12-31	Free cash flow	-70218000	Operating Cash Flow: -70096000 Open source Capital Expenditure: 122000 Open source
20192019-12-31	Free cash flow	-149278000	Operating Cash Flow: -147726000 Open source Capital Expenditure: 1552000 Open source
20202020-12-31	Free cash flow	-275898000	Operating Cash Flow: -271531000 Open source Capital Expenditure: 4367000 Open source
20212021-12-31	Free cash flow	-398595000	Operating Cash Flow: -388800000 Open source Capital Expenditure: 9795000 Open source
20222022-12-31	Free cash flow	-575421000	Operating Cash Flow: -570570000 Open source Capital Expenditure: 4851000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

17.1% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	23.9%	Total Liabilities: 15135000 Open source Total Assets: 63444000 Open source
20172017-12-31	Liabilities / assets	8.9%	Total Liabilities: 13958000 Open source Total Assets: 157246000 Open source
20182018-12-31	Liabilities / assets	11.8%	Total Liabilities: 26878000 Open source Total Assets: 228454000 Open source
20192019-12-31	Liabilities / assets	11.5%	Total Liabilities: 49905000 Open source Total Assets: 432200000 Open source
20202020-12-31	Liabilities / assets	7.8%	Total Liabilities: 115339000 Open source Total Assets: 1476128000 Open source
20212021-12-31	Liabilities / assets	12.1%	Total Liabilities: 191716000 Open source Total Assets: 1588754000 Open source
20222022-12-31	Liabilities / assets	17.1%	Total Liabilities: 206131000 Open source Total Assets: 1202647000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.96× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	3.97×	Current Assets: 59555000 Open source Current Liabilities: 15002000 Open source
20172017-12-31	Current assets / current liabilities	11.42×	Current Assets: 155759000 Open source Current Liabilities: 13644000 Open source
20182018-12-31	Current assets / current liabilities	8.67×	Current Assets: 226660000 Open source Current Liabilities: 26146000 Open source
20192019-12-31	Current assets / current liabilities	8.68×	Current Assets: 424407000 Open source Current Liabilities: 48906000 Open source
20202020-12-31	Current assets / current liabilities	19.64×	Current Assets: 1403643000 Open source Current Liabilities: 71472000 Open source
20212021-12-31	Current assets / current liabilities	10.5×	Current Assets: 1507983000 Open source Current Liabilities: 143658000 Open source
20222022-12-31	Current assets / current liabilities	6.96×	Current Assets: 1108961000 Open source Current Liabilities: 159448000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	−USD 52.86 million Exact value Exact value: -52859000 USD 2013-01-01 – 2013-12-31: -52859000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRATI THERAPEUTICS, INC. · 2013-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Net Income: -52859000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -52859000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828016012476/mrtx-20151231.xml#231204 Filing: 000162828016012476 The citation records this snapshot. The page link may show a newer release later.	−USD 29.46 million Exact value Exact value: -29455000 USD 2013-01-01 – 2013-12-31: -29455000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRATI THERAPEUTICS, INC. · 2013-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Operating Cash Flow: -29455000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29455000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828016012476/mrtx-20151231.xml#230568 Filing: 000162828016012476 The citation records this snapshot. The page link may show a newer release later.	USD 204,000 Exact value Exact value: 204000 USD 2013-01-01 – 2013-12-31: 204000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRATI THERAPEUTICS, INC. · 2013-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Capital Expenditure: 204000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 204000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828016012476/mrtx-20151231.xml#250712 Filing: 000162828016012476 The citation records this snapshot. The page link may show a newer release later.	−USD 29.66 million Calculation and evidence -29455000 − 204000 USD Exact free cash flow: -29659000 USD 2013-01-01 – 2013-12-31: -29455000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 204000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRATI THERAPEUTICS, INC. · 2013-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Free cash flow: -29659000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29455000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828016012476/mrtx-20151231.xml#230568 Filing: 000162828016012476 Input fundies:CapitalExpenditure: 204000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828016012476/mrtx-20151231.xml#250712 Filing: 000162828016012476 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 43.7 million Exact value Exact value: -43698000 USD 2014-01-01 – 2014-12-31: -43698000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRATI THERAPEUTICS, INC. · 2014-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Net Income: -43698000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43698000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828017002407/mrtx-20161231.xml#187976 Filing: 000162828017002407 The citation records this snapshot. The page link may show a newer release later.	−USD 32.75 million Exact value Exact value: -32748000 USD 2014-01-01 – 2014-12-31: -32748000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRATI THERAPEUTICS, INC. · 2014-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Operating Cash Flow: -32748000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32748000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828017002407/mrtx-20161231.xml#187340 Filing: 000162828017002407 The citation records this snapshot. The page link may show a newer release later.	USD 386,000 Exact value Exact value: 386000 USD 2014-01-01 – 2014-12-31: 386000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRATI THERAPEUTICS, INC. · 2014-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Capital Expenditure: 386000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 386000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828017002407/mrtx-20161231.xml#208319 Filing: 000162828017002407 The citation records this snapshot. The page link may show a newer release later.	−USD 33.13 million Calculation and evidence -32748000 − 386000 USD Exact free cash flow: -33134000 USD 2014-01-01 – 2014-12-31: -32748000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 386000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRATI THERAPEUTICS, INC. · 2014-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Free cash flow: -33134000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32748000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828017002407/mrtx-20161231.xml#187340 Filing: 000162828017002407 Input fundies:CapitalExpenditure: 386000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828017002407/mrtx-20161231.xml#208319 Filing: 000162828017002407 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 64.54 million Exact value Exact value: -64544000 USD 2015-01-01 – 2015-12-31: -64544000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRATI THERAPEUTICS, INC. · 2015-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Net Income: -64544000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -64544000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828018002942/mrtx-20171231.xml#187088 Filing: 000162828018002942 The citation records this snapshot. The page link may show a newer release later.	−USD 50.71 million Exact value Exact value: -50714000 USD 2015-01-01 – 2015-12-31: -50714000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRATI THERAPEUTICS, INC. · 2015-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Operating Cash Flow: -50714000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -50714000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828018002942/mrtx-20171231.xml#186452 Filing: 000162828018002942 The citation records this snapshot. The page link may show a newer release later.	USD 329,000 Exact value Exact value: 329000 USD 2015-01-01 – 2015-12-31: 329000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRATI THERAPEUTICS, INC. · 2015-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Capital Expenditure: 329000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 329000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828018002942/mrtx-20171231.xml#208215 Filing: 000162828018002942 The citation records this snapshot. The page link may show a newer release later.	−USD 51.04 million Calculation and evidence -50714000 − 329000 USD Exact free cash flow: -51043000 USD 2015-01-01 – 2015-12-31: -50714000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 329000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRATI THERAPEUTICS, INC. · 2015-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Free cash flow: -51043000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -50714000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828018002942/mrtx-20171231.xml#186452 Filing: 000162828018002942 Input fundies:CapitalExpenditure: 329000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828018002942/mrtx-20171231.xml#208215 Filing: 000162828018002942 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 83.12 million Exact value Exact value: -83118000 USD 2016-01-01 – 2016-12-31: -83118000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRATI THERAPEUTICS, INC. · 2016-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Net Income: -83118000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -83118000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828019002289/mrtx-20181231.xml#230225 Filing: 000162828019002289 The citation records this snapshot. The page link may show a newer release later.	−USD 68.02 million Exact value Exact value: -68017000 USD 2016-01-01 – 2016-12-31: -68017000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRATI THERAPEUTICS, INC. · 2016-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Operating Cash Flow: -68017000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -68017000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828019002289/mrtx-20181231.xml#229589 Filing: 000162828019002289 The citation records this snapshot. The page link may show a newer release later.	USD 196,000 Exact value Exact value: 196000 USD 2016-01-01 – 2016-12-31: 196000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRATI THERAPEUTICS, INC. · 2016-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Capital Expenditure: 196000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 196000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828019002289/mrtx-20181231.xml#255340 Filing: 000162828019002289 The citation records this snapshot. The page link may show a newer release later.	−USD 68.21 million Calculation and evidence -68017000 − 196000 USD Exact free cash flow: -68213000 USD 2016-01-01 – 2016-12-31: -68017000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 196000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRATI THERAPEUTICS, INC. · 2016-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Free cash flow: -68213000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -68017000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828019002289/mrtx-20181231.xml#229589 Filing: 000162828019002289 Input fundies:CapitalExpenditure: 196000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828019002289/mrtx-20181231.xml#255340 Filing: 000162828019002289 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 70.43 million Exact value Exact value: -70430000 USD 2017-01-01 – 2017-12-31: -70430000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRATI THERAPEUTICS, INC. · 2017-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Net Income: -70430000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -70430000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828020002301/mrtx-20191231x10k.htm#1200588 Filing: 000162828020002301 The citation records this snapshot. The page link may show a newer release later.	−USD 64.71 million Exact value Exact value: -64706000 USD 2017-01-01 – 2017-12-31: -64706000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRATI THERAPEUTICS, INC. · 2017-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Operating Cash Flow: -64706000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -64706000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828020002301/mrtx-20191231x10k.htm#1226323 Filing: 000162828020002301 The citation records this snapshot. The page link may show a newer release later.	USD 81,000 Exact value Exact value: 81000 USD 2017-01-01 – 2017-12-31: 81000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRATI THERAPEUTICS, INC. · 2017-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Capital Expenditure: 81000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 81000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828020002301/mrtx-20191231x10k.htm#1237773 Filing: 000162828020002301 The citation records this snapshot. The page link may show a newer release later.	−USD 64.79 million Calculation and evidence -64706000 − 81000 USD Exact free cash flow: -64787000 USD 2017-01-01 – 2017-12-31: -64706000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 81000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRATI THERAPEUTICS, INC. · 2017-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Free cash flow: -64787000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -64706000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828020002301/mrtx-20191231x10k.htm#1226323 Filing: 000162828020002301 Input fundies:CapitalExpenditure: 81000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828020002301/mrtx-20191231x10k.htm#1237773 Filing: 000162828020002301 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 98.42 million Exact value Exact value: -98418000 USD 2018-01-01 – 2018-12-31: -98418000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRATI THERAPEUTICS, INC. · 2018-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Net Income: -98418000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -98418000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828021003315/mrtx-20201231.htm#1000159 Filing: 000162828021003315 The citation records this snapshot. The page link may show a newer release later.	−USD 70.1 million Exact value Exact value: -70096000 USD 2018-01-01 – 2018-12-31: -70096000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRATI THERAPEUTICS, INC. · 2018-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Operating Cash Flow: -70096000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -70096000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828021003315/mrtx-20201231.htm#1031597 Filing: 000162828021003315 The citation records this snapshot. The page link may show a newer release later.	USD 122,000 Exact value Exact value: 122000 USD 2018-01-01 – 2018-12-31: 122000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRATI THERAPEUTICS, INC. · 2018-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Capital Expenditure: 122000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 122000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828021003315/mrtx-20201231.htm#1042529 Filing: 000162828021003315 The citation records this snapshot. The page link may show a newer release later.	−USD 70.22 million Calculation and evidence -70096000 − 122000 USD Exact free cash flow: -70218000 USD 2018-01-01 – 2018-12-31: -70096000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 122000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRATI THERAPEUTICS, INC. · 2018-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Free cash flow: -70218000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -70096000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828021003315/mrtx-20201231.htm#1031597 Filing: 000162828021003315 Input fundies:CapitalExpenditure: 122000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828021003315/mrtx-20201231.htm#1042529 Filing: 000162828021003315 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 213.26 million Exact value Exact value: -213256000 USD 2019-01-01 – 2019-12-31: -213256000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRATI THERAPEUTICS, INC. · 2019-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Net Income: -213256000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -213256000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828022004246/mrtx-20211231.htm#1065098 Filing: 000162828022004246 The citation records this snapshot. The page link may show a newer release later.	−USD 147.73 million Exact value Exact value: -147726000 USD 2019-01-01 – 2019-12-31: -147726000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRATI THERAPEUTICS, INC. · 2019-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Operating Cash Flow: -147726000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -147726000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828022004246/mrtx-20211231.htm#1102346 Filing: 000162828022004246 The citation records this snapshot. The page link may show a newer release later.	USD 1.55 million Exact value Exact value: 1552000 USD 2019-01-01 – 2019-12-31: 1552000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRATI THERAPEUTICS, INC. · 2019-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Capital Expenditure: 1552000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1552000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828022004246/mrtx-20211231.htm#1113072 Filing: 000162828022004246 The citation records this snapshot. The page link may show a newer release later.	−USD 149.28 million Calculation and evidence -147726000 − 1552000 USD Exact free cash flow: -149278000 USD 2019-01-01 – 2019-12-31: -147726000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1552000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRATI THERAPEUTICS, INC. · 2019-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Free cash flow: -149278000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -147726000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828022004246/mrtx-20211231.htm#1102346 Filing: 000162828022004246 Input fundies:CapitalExpenditure: 1552000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828022004246/mrtx-20211231.htm#1113072 Filing: 000162828022004246 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 357.94 million Exact value Exact value: -357937000 USD 2020-01-01 – 2020-12-31: -357937000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRATI THERAPEUTICS, INC. · 2020-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Net Income: -357937000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -357937000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1079160 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.	−USD 271.53 million Exact value Exact value: -271531000 USD 2020-01-01 – 2020-12-31: -271531000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRATI THERAPEUTICS, INC. · 2020-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Operating Cash Flow: -271531000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -271531000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1129105 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.	USD 4.37 million Exact value Exact value: 4367000 USD 2020-01-01 – 2020-12-31: 4367000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRATI THERAPEUTICS, INC. · 2020-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Capital Expenditure: 4367000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4367000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1139833 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.	−USD 275.9 million Calculation and evidence -271531000 − 4367000 USD Exact free cash flow: -275898000 USD 2020-01-01 – 2020-12-31: -271531000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 4367000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRATI THERAPEUTICS, INC. · 2020-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Free cash flow: -275898000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -271531000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1129105 Filing: 000162828023005576 Input fundies:CapitalExpenditure: 4367000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1139833 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 581.78 million Exact value Exact value: -581784000 USD 2021-01-01 – 2021-12-31: -581784000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRATI THERAPEUTICS, INC. · 2021-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Net Income: -581784000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -581784000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1077984 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.	−USD 388.8 million Exact value Exact value: -388800000 USD 2021-01-01 – 2021-12-31: -388800000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRATI THERAPEUTICS, INC. · 2021-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Operating Cash Flow: -388800000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -388800000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1128048 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.	USD 9.8 million Exact value Exact value: 9795000 USD 2021-01-01 – 2021-12-31: 9795000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRATI THERAPEUTICS, INC. · 2021-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Capital Expenditure: 9795000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9795000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1138845 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.	−USD 398.6 million Calculation and evidence -388800000 − 9795000 USD Exact free cash flow: -398595000 USD 2021-01-01 – 2021-12-31: -388800000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 9795000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRATI THERAPEUTICS, INC. · 2021-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Free cash flow: -398595000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -388800000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1128048 Filing: 000162828023005576 Input fundies:CapitalExpenditure: 9795000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1138845 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 740.87 million Exact value Exact value: -740867000 USD 2022-01-01 – 2022-12-31: -740867000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRATI THERAPEUTICS, INC. · 2022-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Net Income: -740867000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -740867000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1076808 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.	−USD 570.57 million Exact value Exact value: -570570000 USD 2022-01-01 – 2022-12-31: -570570000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRATI THERAPEUTICS, INC. · 2022-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Operating Cash Flow: -570570000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -570570000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1126991 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.	USD 4.85 million Exact value Exact value: 4851000 USD 2022-01-01 – 2022-12-31: 4851000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRATI THERAPEUTICS, INC. · 2022-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Capital Expenditure: 4851000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4851000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1137857 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.	−USD 575.42 million Calculation and evidence -570570000 − 4851000 USD Exact free cash flow: -575421000 USD 2022-01-01 – 2022-12-31: -570570000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 4851000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRATI THERAPEUTICS, INC. · 2022-12-31 MIRATI THERAPEUTICS, INC. (edgar:1576263) Free cash flow: -575421000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576263?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -570570000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1126991 Filing: 000162828023005576 Input fundies:CapitalExpenditure: 4851000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828023005576/mrtx-20221231.htm#1137857 Filing: 000162828023005576 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

52 filings · 2,791 latest values · 2,791 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001576263, 1576263, MRTX, edgar:1576263

Also known as MIRATI THERAPEUTICS, INC., Mirati Therapeutics, INC., Mirati Therapeutics, Inc.

MIRATI THERAPEUTICS, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation